Annual / Quarterly Financial Statement • Oct 1, 2015
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer
(published in accordance with L. 2190, article 135, regarding companies preparing annual financial statements, consolidated or not, in accordance with the I.F.R.S.) The following data and information aim at providing view of the financial position and the results of the Group and the company AXON HOLDINGS S.A. Interested parties who seek to obtain a full account of the Company's finan Independent Auditor. Indicatively, they can access the company's web site, www.axonholdings.gr, where the aforementioned infomation is posted.
| Company Registered Offices: Foundation Date: |
INCOME STATEMENT (All amounts in thousands of Euro €) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 04/12/1987 G.N 2957/23.12.87 Main Activity: Holdings Company 16226/06/B/87/17 S.A. Registration No: |
GROUP 1/1-31/12/07 1/1-31/12/06 |
COMPANY 1/1-31/12/07 1/1-31/12/06 |
|||||||
| Supervising Authority: and Credit |
Ministry of Development, Administration of S.A.'s | Sales Gross profit |
222.085 54.439 |
201.895 61.542 |
n 0 |
n 0 |
|||
| Members of the Board of Directors: Terzopoulos Apostolos (President), Doumanoglou Panagiotis (Managing Director), Nanopoulos |
Profits before taxes, financing results, investment results and depreciation |
34.984 | 48.495 | 705 | 1.844 | ||||
| Dimitrios (Member), Nikolaidis Petros (Member) Paka Paraskeui (Member) Approval date of the Financial Statements (out of |
Profit before taxes, financing and ivnestment results Results before income taxes |
23.139 33.220 |
38.665 31.151 |
703 6.589 |
1.843 2.133 |
||||
| which the brief financial statements were drawn): Independent Auditor: |
26 March 2008 | Koutras Grigorios, SOEL R.N. 13601 | Minus Income taxes Results after income taxes from continued |
(15.017) | (15.384) | (1.429) | (3.834) | ||
| Auditing Firm: Audit Report Type: |
BDO PROTYPOS HELLENIC AUDITING Co S.A. | Unqualified opinion - matters of emphasis | operations (a) Results after income taxes from discontinued |
18.203 | 15.767 | 5.160 | (1.701) | ||
| www.axonholding.gr Company web site: |
operations (b) Results after income taxes form continued and |
0 | 0 | 0 | 0 | ||||
| BALANCE SHEET as of 31st December 2007 (All amounts in thousands of Euro $\epsilon$ ) |
discontinued operations) $(a) + (b)$ Attributable to: |
18.203 | 15.767 | 5.160 | (1.701) | ||||
| ASSETS | GROUP 31/12/2007 31/12/2006 |
COMPANY 31/12/2007 31/12/2006 |
Company shareholders Minority shareholders |
5.956 12.247 |
3.294 12.473 |
5.160 0 |
(1.701) $\Omega$ |
||
| Tangible assets & Intangible assets Inventories |
490.791 25.650 |
325.835 27.223 |
165.358 1.118 |
85.720 0 |
Earnings after taxes per share (in Euro) | 0,20 | 0,12 | 0,16 | (0.05) |
| Trade receivables Other Assets |
96.205 197.720 |
83.832 85.707 |
0 3.333 |
0 3.701 |
CASH FLOW STATEMENT (All amounts in thousands of Euro €) |
||||
| TOTAL ASSETS EQUITY AND LIABILITIES |
810.366 | 522.598 | 169.809 | 89.422 | 1/1-31/12/07 | GROUP | COMPANY 1/1-31/12/07 1/1-31/12/06 |
||
| Non-Current Liabilities Current Bank Liabilities |
172.563 148.366 |
79.572 86.987 |
14.064 33.730 |
1.189 16.086 |
Cash flows from operating activies: Profit before income taxes |
33.220 | 1/1-31/12/06 31.151 |
6.589 | 2.133 |
| Other Current Liabilities Total Liabilities (a) |
230.843 551.772 |
214.785 381.344 |
18.028 65.821 |
8.416 25.691 |
Plus (minus) adjustements for: Depreciation and amortisation expenses |
11.845 | 9.830 | 3 | -1 |
| Share Capital Other items of Shareholders' Equity |
24.712 100.427 |
19.222 33.848 |
24.712 79.276 |
19.222 44.509 |
Provisions Loss / (gain) on disposal of fixed assets |
1.831 1.675 |
2.452 (1.048) |
(839) n |
(1.880) 0 |
| Total Equity attributable to Share holders (b) Minority Interests (c) |
125.139 133.456 |
53.070 88.184 |
103.988 n |
63.731 0 |
Loss / (gain) on investments Income from depreciation of fixed assets grants |
(19.098) (286) |
(837) (29) |
(4.961) n |
(236) 0 |
| Total Equity $(d) = (b) + (c)$ TOTAL EQUITY AND LIABILITIES (a) + (d) |
258.594 810.366 |
141.254 522.598 |
103.988 169.809 |
63.731 89.422 |
Income from participations Loss / (gain) from participating interests |
(38) 227 |
(19) 4 |
(2.765) n |
(980) 0 |
| STATEMENT OF CHANGES IN EQUITY | Debit interest and other related expenses | 12.165 41.540 |
7.746 49.249 |
1.346 (626) |
925 (36) |
||||
| (All amounts in thousands of Euro €) | GROUP | COMPANY | Plus / (minus) adjustments for changes in working capital | ||||||
| Equity at the beginning of the year | 1/1-31/12/07 1/1-31/12/06 1/1-31/12/07 1/1-31/12/06 | or operatiing activities accounts: Decrease / (Increase) in Inventories |
1.717 | (9.536) | $\mathbf{0}$ | 0 | |||
| (01/01/2007 and 01/01/2006) Results after income taxes |
141.254 18.203 |
126.586 15.767 |
63.731 5.160 |
65.747 (1.701) |
Decrease / (Increase) in receivables Decrease / (Increase) in Non-Current receivables (Decrease) / Increase in liabilities (except bank loans) |
(46.891) 1.357 53.786 |
(16.724) 1.784 3.350 |
4.083 (6) 468 |
(383) 0 2.212 |
| Increase in share capital Dividends |
35.960 (6.860) |
0 (1.706) |
35.960 0 |
0 (315) |
(Minus): | ||||
| Net income directly attributable in equity (Purchases) / Sales of treasury shares |
59.305 10.732 |
663 (56) |
0 (863) |
0 0 |
Debit interest and other related expenses paid Income taxes paid |
(13.725) (9.130) |
(8.241) (6.986) |
(1.346) (1.429) |
(925) (925) |
| Other adjustments Equity at the end of the period (31/12/2007 |
0 | 0 | 0 | 0 | Total Cash flows from operating activities (a) Cash Flows from Investing Activities: |
28.654 | 12.896 | 1.144 | (57) |
| and 31/12/2006) | 258.594 | 141.254 | 103.988 | 63.731 | Acquisition of subsidiaries, associates, joint ventures and other investments |
(119.576) | (8.285) | (24.861) | (197) |
| ADDITIONAL DATA AND INFORMATION | Purchase of treasury shares Purchase of tangible and intangible assets |
(863) (35.710) |
(12) (22.908) |
(863) (5) |
0 $[4]$ |
||||
| 1. The companies included in the consolidated financial statements of the closing year are the following. A. Total consolidation method |
Country | Participating | Unaudited | Proceeds from tangible and intangible assets sales Proceeds from financial assets and investments sales |
6.585 32.387 |
1.511 3.082 |
n 8.291 |
0 302 |
|
| AXON HOLDINGS S.A. | Hellas | interest parent company |
Years 2005-2007 |
Proceeds from financial assets Interest received |
837 723 |
490 | n | 0 0 |
|
| EUROMEDICA S.A. HELLENIC OPTHALMOLOGICAL CENTER ORASIS S.A. |
Hellas Hellas |
57,10% 40,54% |
2006-2007 2007 |
Proceeds from grants for investements in fixed assets Dividends received |
926 n |
n 19 |
n 2.278 |
0 689 |
|
| IPPOKRATIS CENTER OF NUCLEAR MEDICINE S.A. MEDICAL DIAGNOSTIC CENTER VOLOS «YGEIA VOLOU» S.A. |
Hellas Hellas |
34,26% 29,12% |
2005-2007 2004-2007 |
Total Cash Flows from Investing Activities (b) | (114.692) | (26.098) | (15.160) | 790 | |
| MELAMBUS MEDICINE S.A. OBSTETRIC GYNECOLOGICAL CLINIC «THEOTOKOS» S.A. |
Hellas Hellas |
42,40% 40,35% |
2007 2007 |
Cash Flows from Financing Activites: Proceeds from share capital increase |
0 | 0 | 0 | 0 | |
| EUROMEDICA MULTIDIAGNOSTIC CENTER LARISA S.A. PRIVATE DIAGNOSTIC CENTER PYLI AKSIOU S.A. |
Hellas Hellas |
39,97% 42,42% |
2007 2003-2007 |
Proceeds (repayments) of loans Payments of leases liabilities |
104.708 7.516 |
22.624 (3.686) |
14.829 n |
(317) 0 |
|
| OBSTETRIC GYNECOLOGICAL CLINIC THESSALONIKI «GENESIS» S.A. EUROMEDICA AROGI MEDICAL CENTER APOKATASTASI S.A. |
Hellas Hellas |
28,55% 51,39% |
2007 2003-2007 |
Dividends paid Board of Directors' fees |
(8.242) (386) |
(1.845) (531) |
(662) | (459) | |
| GENERAL CLINIC OF DODEKANISA S.A. EURO PROCUREMENT S.A. |
Hellas Hellas |
32,77% 57,02% |
2003-2007 2007 |
Total Cash Flows from Financing Activities (c) Net increase / (decrease) in cash and cash |
103.596 | 16.562 | 14.167 | (777) | |
| SONAK S.A. AXON SECURITIES |
Hellas Hellas |
52,51% 40,00% |
2005-2007 2005-2007 |
equivalents $(a)+(b)+(c)$ Cash and cash equivalents at the beginning of year |
17.559 13.146 |
3.360 9.785 |
151 73 |
(44) 117 |
|
| ELSON S.A. DATA DESIGN S.A. |
Hellas Hellas |
52,51% 45,62% |
2003-2007 2003-2007 |
Cash and cash equivalents of merged companies Cash and cash equivalents at the end of year |
139 30.843 |
n 13.146 |
139 363 |
0 73 |
|
| PRISMA TECHNICS S.A. NEOS EGEFALOS S.A. |
Hellas Hellas |
27,68% 62,35% |
2005-2007 2003-2007 |
people respectively. | |||||
| MAGNETIC TOMOGRAPHY VOLOS S.A. SERRES AXONIKOS TOMOGRAPHOS S.A. |
Hellas Hellas |
18,56% 26,84% |
2003-2007 2003-2007 |
7. Investments in fixed assets during the current period came up to: € 5 k. for the Company and € 35.710 k. for the Group. 8. At 31 December 2007 the decision numbered K2-17814/21-12-2007 was approved by the Ministry of Development regarding the |
|||||
| PROLIPTIKI IATRIKI P. FALIROU L.T.D. YGEIA MAGNETIC DIAGNOSI PTOLEMAIDA S.A. |
Hellas Hellas |
27,94% 27,98% |
2006-2007 2003-2007 |
break up contract plan of the company ACHAIKI INDUSTRY OF ADVANCED TECHNOLOGY S.A. with S.A. registration no 42412/22/B/99/23, according to which, the branch "Production of advanced technology products and services, buildings, lands and technical projects" of the company is broken up and absobed by the parent company of the Group AXON HOLDINGS S.A. and the |
|||||
| EUROMEDICA FINANCE No 1 S.A. TOURISTIC ENTERPRISES W. MACEDONIA S.A. |
Luxembourg Hellas |
57,10% 51,39% |
2007 2003-2007 |
Investments' branch by the associated company of the Group MYSTRAS S.A. INVESTMENTS AND BUSINESS PARTICIPATION according to the decision of the General Meeting of the shareholders dated 8/12/07, according to the provisions of articles 81-85 of |
|||||
| EGEFALOS PELOPONNISOU S.A. «ARISTOTELEIO» PRIVATE DIAGNOSTIC LABORATORY |
Hellas | 100% | 2003-2007 | [CL 2190/1920 and the articles 1-5 of the L. 2166/1993 (see Note 7 to the annual financial statements). 9. A share capital increase was decided by the Extraordinary General Meeting of the Group's Subsidiary Company EUROMEDICA S.A. |
|||||
| AXONIKOS TOMOGRAPHOS MEDICAL S.A. AXIAL AND DIAGNOSTIC KORINTHOS S.A. |
Hellas Hellas |
29,78% 23,42% |
2003-2007 2004-2007 |
shareholders on 30/6/2007, by issuing 7.500.000 new common shares, of nominal value 1,55 € each, in cash and by partial cancellation of the old shareholders preemptive right. The new shares were offered in favour of the company HEALTHCARE |
|||||
| MEDINET ALEXANDROUPOLI S.A. AROGI S.A. APOKASTASI S.A. |
Hellas Hellas Hellas |
27,98% 28,55% 28,55% |
2003-2007 2006-2007 2006-2007 |
INVESTORS (GREECE) L.L.C. and the company AXON HOLDINS S.A. The issue price of the new shares was 8,00 € per share. The aforementioned share capital increase of the Company was approved by the decision numbered K2-1628/11-7-2007 of teh Ministry |
|||||
| EUROMEDICA ANATOLIKI ATTIKI PRIVATE MULDIMEDICAL CENTER S.A. IONIOS GENERAL CLINIC S.A. UTILISATION AND FUCTION OPERATOR |
Hellas | 41,00% | 2007 | of Development and after the fulfillmen of the share capital increase procedure, the new shares were listed in the Athens Stock Exchange on 28/8/2007, and they are entitled to receive dividend from the profits of the year 2007. |
|||||
| QUARANTINE ABSTRACTION S.A. (CORFU) IATRIKI MEGARON PRIVATE DIAGNOSTIC LABORATORY S.A. |
Hellas Hellas |
28,55% 42,83% |
2004-2007 2006-2007 |
10. The Boards of Directors of the parent company of the Group EUROMEDICA S.A. and its subsidiary companies GENERAL CLINIC OF THESSALONIKI S.A., MEDICAL CENTER OF ADVANCED TECHNOLOGY KRITI S.A. and MEDICAL INSTITUTE OF ADVANCED |
|||||
| IONIA PRIVATE POLYIATRIO IATRIKI S.A. IONIA NEFROLOGIKI UNIT OF CHRONIC HEMODIALYSIS S.A. |
Hellas Hellas |
51,39% 27,98% |
2006-2007 2006-2007 |
TECHNOLOGY WEST MACEDONIA S.A. decided, at 28/9/2007, the merger by absorption of th given three subsidiaries by the parent companny EUROMEDICA S.A The 30th of September 2007 was appointed as transformation date and the merger was accomplished according to the provisions of L. 2166/1993 and of C.L. 2190/1920. The aforementioned merger was approved by the |
|||||
| GALINOS MEDICAL DIAGNOSTIC TRIKALON S.A. MULTIDIAGNOSTIC CENTER OF PIERIA S.A. |
Hellas Hellas |
25,70% 38,18% |
2005-2007 2003-2007 |
decision numberd K2-18601/31-12-2007 of the Ministry of Development (see Note 8 to the annual financial statements). 11. The cumulative amounts of sales and purchases from the opening of the fiscal year and the balances of claims and liabilities of |
|||||
| B. Equity Method EUROGENETIC S.A. PROTYPOS CENTRE OF RESEARCH AND APPLICATION |
the Group and the Company to the end of the current year, regarding from transactions with related parties, as dictated by IAS 24, are as follows (amounts in thousands of euro $\epsilon$ ): |
||||||||
| OF MOLECULAR BIOLOGY MEDITRON S.A. |
Hellas Hellas |
22,84% 22,81% |
2006-2007 2003-2007 |
a) Sales of goods and services | GROUP 529 |
COMPANY 359 |
|||
| DORMED HELLAS S.A. N. IONIA AXIAL TOMOGRAPHY S.A. |
Hellas Hellas |
19,96% 22,84% |
2003-2007 2004-2007 |
b) Purchases of goods and services c) Receivables |
2.144 35.117 |
25 7.837 |
|||
| MEDECINE DIAGNOSTIC LABORATORY KOZANI MEDICINE S.A. PRIVATE POLYIATRIO IATRIKI S.A. (MEDICINE DIAGNOSIS OF LESVOS S.A.) |
Hellas Hellas |
11,99% 19,99% |
2007 2007 |
d) Liabilities e) Transaction and fees of management executives and administration members |
11.447 3.470 |
11.301 0 |
|||
| MEDINET KAVALAS PRIVATE DIAGNOSTIC CENTER S.A. 2. The matters of emphasis which the independent Auditor is referred to in the Audit Report, concern: a) pending law suits, b) |
Hellas | 19,42% | 2003-2007 f) Receivables from managerial executives and administration members g) Liabilities to management executives and administration members |
0 0 |
n 0 |
||||
| unaudited years by tax authorities. 3. At 1/1/2007, the Group's Management decided to change the accounting policy of the privately owned property (land and buildings) from that of historical cost to revaluation in the fair value in frequent time intervals. The emerging goodwill fo the Group amounted to € 48.496 k. resulting in the increase of the Group's and the Company's equity by the amount of € 36,37 k. (from which e 17.807 k. was attributable to minority shareholdes), after the deduction of the deferred tax liability amounting to € 12.124 k. (see LABORATORY S.A., IONIA PRIVATE POLYIATRIO IATRIKI S.A., IONIA NEFROLOGIKI UNIT OF CHRO Note 9 to the annual financial statements). 4. Prenotes on the property and land of the Company and the Group of total amount $\epsilon$ 14,3 mil. $\kappa$ at $\epsilon$ 94,4 mil. respectively have been recorded as loan quarantees. 5. There are raised law suits against companies of the Group claiming in total $\epsilon$ 49,6 mil., the biggest part of whom is covered by special insurance contracts. Furthemore, a legal recourse has been taken by a subsidiary company for unresolved tax differences concerning an amount of $\epsilon$ 11,5 mil approximately. It is estimated that the lawsuits will have no material effect on the economic position of the Group. |
12. In the consolidated financial statements of the current year are included for the first time the financial statements of the companies: YGEIA MAGNETIC DIAGNOSI S.A., TOURISTIC ENTERPRISES W. MACEDONIA S.A., PRIVATE DIAGNOSTIC LABORATORY ARISTOTELEIO AXIAL TOMOGRAPHY MEDICAL S.A. and EUROMEDICA FINANCE No 1 S.A., DATA DESIGN S.A., AXIAL AND DIAGNOSTIC KORINTHOS S.A., MEDINET ALEXANDROUPOLI S.A., AROGI S.A., APOKATASTASI S.A., EUROMEDICA ANATOLIKI ATTIKI PRIVATE MULTIMEDICAL CENTER S.A., IONIOS GENERAL CLINIC S.A. (CORFU), IATRIKI MEGARON PRIVATE DIAGNOSTIC GALINOS MEDICAL DIAGNOSTIC TRIKALON S.A., and MULTIDAIGNOSTIC CENTER OF PIERIAS S.A. which were included for the first time with the consolidated method beginning from 1/1/2007, 1/4/2007, 1/4/2007, 30/6/2007, 1/9/2007, 30/9/2007, 1/9/2007, 1/9/2007, 1/7/2007, 31/12/2007, 6/12/2007, 1/10/2007, 1/10/2007, 1/10/2007, 23/11/2007, and 1/11/2007 respectively. Addiitionally, the associated companies EUROGENETIKI S.A., MEDITRON S.A., DORMED HELLAS S.A., N. IONIA AXIAL TOMOGRAPHY S.A., MEDECINE DIAGNOSTIC LABORATORY KOZANI MEDICINE S.A., PRIVATE POLYIATRIO IATRIKI S.A. (MEDICINE DIAGNOSIS OF LESVOS S.A.) and MEDINET KAVALAS PRIVATE DIAGNOSTIC CENTER S.A. which were consolidated for the first time with the equity method beginning from 1/11/2006, 31/12/2006, 1/6/2007, 30/6/2007, 1/10/2007, 1/11/2007 and 31/12/2007 |
||||||||
| 6. The number of personnel of the Company and the Group at the end of the current year was 14 (2006: 4) and 2.269 (2006: 1.899) respectively. Athens, March 26, 2008 |
|||||||||
| The Chief Executive Director TERZOPOULOS APOSTOLOS |
The Managing Director DOUMANOGLOU PANAGIOTIS |
Head of Accounting Department LIAKOS LOUKAS |
|||||||
| ID. No S 636315/98 | ID. No. S 2322215/00 | ID. No. T 017003 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.